Name: | (1R,5S)-3-ethyl-Bicyclo[3.2.0]hept-3-en-6-one (Mirogabalin Besylate Intermediate) |
---|---|
CAS:: | 1235479-61-4 |
Chiral purity: | NLT 99.0 |
Purity: | NLT 99.0 |
Standard: | In-house |
Documentation: | CMC |
Development stage: | Commercialization |
Mirogabalin Besylate Intermediate
Mirogabalin (brand name Tarlige; developmental code name DS-5565) is a medication developed by Daiichi Sankyo, a gabapentinoid. Gabapentin and pregabalin are also members of this class. As a gabapentinoid, mirogabalin binds to the α2δ subunit of voltage-gated calcium channel (1 and 2), but with significantly higher potency than pregabalin.